Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Intangibles (2016 - 2025)

Avanos Medical's Intangibles history spans 9 years, with the latest figure at $239.5 million for Q4 2023.

  • For Q4 2023, Intangibles fell 4.58% year-over-year to $239.5 million; the TTM value through Dec 2023 reached $239.5 million, down 4.58%, while the annual FY2023 figure was $239.5 million, 4.58% down from the prior year.
  • Intangibles for Q4 2023 was $239.5 million at Avanos Medical, down from $242.2 million in the prior quarter.
  • Across five years, Intangibles topped out at $251.0 million in Q4 2022 and bottomed at $145.3 million in Q3 2021.
  • The 4-year median for Intangibles is $231.0 million (2023), against an average of $209.7 million.
  • The largest YoY upside for Intangibles was 4.58% in 2023 against a maximum downside of 4.58% in 2023.
  • A 4-year view of Intangibles shows it stood at $157.7 million in 2020, then decreased by 7.86% to $145.3 million in 2021, then surged by 72.75% to $251.0 million in 2022, then dropped by 4.58% to $239.5 million in 2023.
  • Per Business Quant, the three most recent readings for AVNS's Intangibles are $239.5 million (Q4 2023), $242.2 million (Q3 2023), and $222.6 million (Q2 2023).